Showing 91-100 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
An AI-driven bioelectronics system to accelerate SC-islet maturation Trustees of the University of Pennsylvania Juan Alvarez Cures 01-April-2025 to 01-March-2027 $200,000.00
Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy Trustees of the University of Pennsylvania Michael Betts Cures 01-September-2024 to 31-August-2027 $900,000.00
Targeting self-RNA sensing as a trigger of inflammation in type 1 diabetes Trustees of the University of Pennsylvania Qin Li Cures 01-April-2025 to 31-March-2026 $199,919.54
Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes Trustees of Indiana University Amelia Linnemann Cures 01-October-2023 to 30-September-2026 $560,000.00
β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes Trustees of Indiana University Carmella Evans-Molina Cures 01-March-2026 to 28-February-2029 $748,179.00
Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes Trustees of Indiana University Chaitra Rao Cures 01-March-2024 to 30-April-2027 $228,537.45
Targeting type 1 Diabetes through Polyamines with DFMO Trustees of Indiana University Emily Sims Cures 01-October-2022 to 30-September-2026 $3,693,701.00
Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population Trustees of Indiana University Emily Sims Cures 01-February-2026 to 31-January-2029 $691,694.00
Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes Trustees of Indiana University Jamie Felton Cures 01-February-2026 to 31-January-2029 $682,534.00
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153,000.00